No Data
No Data
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab
Roche (RHHBY.US) receives EU approval for its new generation C5 cyclic antibody Piasky.
On August 28th, Roche announced that the European Commission has approved its new generation C5 complement inhibitor Piasky for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in adult and adolescent patients.
Glytec Expands Global Collaboration With Roche to Revolutionize Hospital Diabetes Management
Roche Gets EU Approval for Blood Disorder Injection PiaSky
Trinity Stock Soars Post-market on Raised Guidance, Increased Capacity
No Data
RDK79 : Sorry, what’s a pdufa?
Xyno RDK79 : Prescription Drug User Fee Act, means FDA approval or rejection for a drug to go to market. One of the most important events to monitor if you are into pharma companies stock.
RDK79 Xyno : Thank you!
Tonyco : What site is that?